Oct 23, 2026 07:30AM
Oct 23, 2026 07:30AM
Oct 15, 2026 05:58AM
Oct 14, 2026 08:30PM
Sep 30, 2026 01:02AM
Sep 30, 2026 01:00AM
Sep 22, 2026 09:30AM Takeda to present phase 3 cancer drug data at ESMO 2026
Sep 22, 2026 09:30AM
Sep 14, 2026 03:00AM
Sep 14, 2026 03:00AM
Aug 28, 2026 06:40PM
Aug 28, 2026 06:40PM
Aug 5, 2026 06:10PM
Aug 5, 2026 06:10PM U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Jul 30, 2026 02:37AM
Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
Mar 2, 2026 06:01AM FDA accepts rusfertide application with priority review for blood disorder
Mar 2, 2026 02:00AM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 8, 2025 02:54AM Protagonist and Takeda report 52-week rusfertide data in polycythemia vera
Dec 6, 2025 09:30AM
Nov 21, 2025 11:54AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM Takeda partners with Innovent for $1.2 billion oncology deal
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
Jul 21, 2025 08:01AM
Jul 21, 2025 08:00AM
Jul 14, 2025 05:55AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM
Jun 3, 2025 10:12AM European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
Jun 1, 2025 08:00AM

335,368 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All